What are the presentation, symptoms, signs, differential diagnosis, and practical questions to ask in a pediatric nephrotic syndrome case?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediatric Nephrotic Syndrome: Case Taking Guide for Practicals

Clinical Presentation

Pediatric nephrotic syndrome classically presents with periorbital edema (most noticeable in the morning), progressing to generalized edema including ascites and scrotal/labial swelling, accompanied by frothy urine. 1, 2

Key Symptoms to Elicit:

  • Edema pattern: Periorbital puffiness (morning), ankle swelling (evening), abdominal distension
  • Urine changes: Frothy/foamy appearance, reduced volume
  • Constitutional symptoms: Fatigue, decreased appetite, irritability
  • Recent infections: Upper respiratory tract infections often precede onset or trigger relapses 3
  • Weight gain: Rapid increase due to fluid retention

Physical Signs to Demonstrate:

  • Edema: Pitting edema in dependent areas, periorbital swelling, ascites (shifting dullness, fluid thrill)
  • Vital signs: Usually normal blood pressure (distinguishes from nephritic syndrome), normal temperature unless infected
  • Skin changes: Shiny, stretched skin over edematous areas; striae if on steroids
  • Respiratory: Pleural effusions causing decreased breath sounds and dullness to percussion
  • Cardiovascular: Normal heart sounds, no signs of heart failure
  • Absence of: Gross hematuria, hypertension, signs of chronic liver disease 4, 5

Differential Diagnosis

Primary Nephrotic Syndrome (Most Common in Children):

  • Minimal change disease (85-90% in children 1-10 years) - most likely diagnosis 5, 2
  • Focal segmental glomerulosclerosis (10-15%)
  • Membranoproliferative glomerulonephritis (rare)
  • Membranous nephropathy (rare in children)

Secondary Causes to Exclude:

  • Systemic lupus erythematosus (lupus nephritis) - check for rash, arthritis, fever 5
  • Henoch-Schönlein purpura - look for purpuric rash, abdominal pain
  • Hepatitis B/C infection
  • HIV-associated nephropathy
  • Malignancy-associated (rare)
  • Drug-induced (NSAIDs, gold, penicillamine)

Conditions to Differentiate From:

  • Nephritic syndrome: Hematuria, hypertension, reduced GFR, less severe proteinuria 5
  • Acute glomerulonephritis: Gross hematuria, hypertension, oliguria
  • Congestive heart failure: Elevated JVP, hepatomegaly, cardiomegaly
  • Chronic liver disease: Jaundice, spider nevi, hepatosplenomegaly, no heavy proteinuria 4
  • Protein-losing enteropathy: Diarrhea, no proteinuria
  • Malnutrition/kwashiorkor: Poor nutritional history, no proteinuria

Essential Questions for Practical Examination

History Taking - Disease Characterization:

  1. Onset and duration: "When did you first notice the swelling? Which part of the body swelled first?"
  2. Urine appearance: "Have you noticed any changes in the urine color or foaminess?"
  3. Previous episodes: "Has this happened before? How many times?" (defines relapse pattern) 3
  4. Infection triggers: "Did your child have a cold, sore throat, or any infection before the swelling started?" 3

Treatment History (Critical for Classification):

  1. Steroid response: "Has your child received steroids before? Did the swelling go away with steroids? How quickly?" (defines steroid-sensitive vs resistant) 3
  2. Relapse frequency: "How many times has the swelling come back in the last 6 months? In the last year?" (defines frequently-relapsing vs infrequently-relapsing) 3
  3. Current medications: "What medicines is your child taking now? Any immunosuppressants like cyclosporine, tacrolimus, or rituximab?" 3
  4. Steroid toxicity: "Have you noticed growth problems, weight gain, mood changes, or bone problems?" 3

Complications Assessment:

  1. Infection risk: "Any fever, abdominal pain, or signs of infection?" (spontaneous bacterial peritonitis risk) 2
  2. Thrombosis symptoms: "Any limb pain, swelling in one leg, chest pain, or breathing difficulty?" 4, 2
  3. Acute kidney injury: "Has urine output decreased significantly?" 2

Family and Genetic History:

  1. Family history: "Does anyone in the family have kidney disease or nephrotic syndrome?" (genetic forms) 6
  2. Ethnicity: "What is your ethnic background?" (higher incidence in Asian and Black populations) 2

Monitoring and Compliance:

  1. Home monitoring: "Do you check urine protein at home with dipsticks? What were recent readings?" 2
  2. Medication adherence: "Are you able to give all medications as prescribed? Any difficulties?" 2

Laboratory Findings to Discuss

Diagnostic Triad (Define Nephrotic Syndrome):

  • Heavy proteinuria: >3+ on dipstick, protein:creatinine ratio >2 mg/mg (>200 mg/mmol), or 24-hour protein >3 g 4, 5
  • Hypoalbuminemia: Serum albumin <3.0 g/dL (30 g/L) 4, 5
  • Edema: Clinical finding 4

Additional Expected Findings:

  • Hyperlipidemia: Elevated cholesterol and triglycerides 4, 5
  • Normal complement levels: C3, C4 normal (helps exclude lupus, post-infectious GN)
  • Normal renal function: Creatinine usually normal initially
  • Microscopic hematuria: May be present but not gross hematuria
  • Lipiduria: Oval fat bodies, fatty casts on urine microscopy

Management Algorithm (Based on KDIGO 2025)

Initial Episode Treatment:

Give oral prednisone/prednisolone for either 8 weeks (4 weeks daily + 4 weeks alternate-day) or 12 weeks (6 weeks daily + 6 weeks alternate-day). 3 The 12-week regimen may reduce relapse risk but increases steroid exposure.

Relapse Management:

  • For infrequent relapses without steroid toxicity: Repeat standard glucocorticoid regimen 3
  • For frequent relapses with steroid toxicity: Shorter taper and initiate steroid-sparing agents 3
  • Do NOT routinely give daily steroids during upper respiratory infections to prevent relapses (updated 2025 recommendation based on PREDNOS2 trial) 3

Steroid-Sparing Agents (When to Use):

Prescribe glucocorticoid-sparing agents for: (1) frequently-relapsing nephrotic syndrome with serious steroid toxicity, or (2) ALL children with steroid-dependent nephrotic syndrome. 3

Agent selection by disease pattern:

  • Frequently-relapsing NS: Cyclophosphamide or levamisole preferred 3
  • Steroid-dependent NS: Mycophenolate mofetil, rituximab, calcineurin inhibitors (cyclosporine/tacrolimus), or cyclophosphamide 3

Steroid-Resistant Nephrotic Syndrome:

Use cyclosporine or tacrolimus as initial second-line therapy. 3 Rituximab achieves remission in approximately 30% of calcineurin inhibitor-resistant cases 3.

Common Pitfalls to Avoid

  1. Missing steroid-resistant NS: If no remission after 4-6 weeks of daily steroids, classify as steroid-resistant and switch to calcineurin inhibitors 3
  2. Over-treating with steroids during infections: The 2025 guidelines now recommend AGAINST routine daily steroids during URTIs 3
  3. Confusing nephrotic with nephritic syndrome: Nephritic has hematuria, hypertension, and worse prognosis 5
  4. Delaying genetic testing: Consider in steroid-resistant cases, congenital NS, or positive family history 6, 7
  5. Inadequate infection surveillance: High risk for spontaneous bacterial peritonitis and sepsis 2
  6. Missing thrombotic complications: Hypercoagulable state requires vigilance 4, 2

Related Questions

What are the differences between nephrotic syndrome and nephritic syndrome in pediatric patients?
Which of the following is NOT a typical feature of nephrotic syndrome: proteinuria >3 g per 24 hours, hypoalbuminemia, peripheral edema, glomerular hematuria, or hyperlipidemia?
What is the most common type of nephrotic syndrome in children who present with abdominal pain?
What is the diagnostic workup for nephritic syndrome?
What are the differential diagnoses for nephrotic syndrome?
What are the primary and secondary differential diagnoses of nephrotic syndrome and which history questions should be asked when taking a clinical history for a patient with suspected nephrotic syndrome?
For a patient with type 2 diabetes and established atherosclerotic cardiovascular disease, is initiating a GLP‑1 receptor agonist appropriate to improve glycemic control and reduce cardiovascular events?
What are the recommended tips and pearls for properly reaming and placing the acetabular cup during a total hip replacement?
In a patient with type 2 diabetes and established atherosclerotic cardiovascular disease, can the high‑dose semaglutide formulation (Wegovy) be used to reduce cardiovascular events and aid weight loss?
Which H2‑receptor antagonist and dosage should be added for sweat‑induced itching that is not controlled by an H1 antihistamine?
What are the possible causes of a heavy, recurrent menorrhagia with clots and left iliac fossa discomfort in a woman whose period began on [DATE], with initial cramps, brief resolution, and no pain, dizziness, or new medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.